Search Results 791-800 of 17973 for sickle cell
1 cells administered following a conditioning lymphodepletion regimen in diffuse large B cell lymphoma (DLBCL) subjects who failed at least two lines of therapy ...
Acalabrutinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Monoclonal antibodies, such as obinutuzumab, may ...
The chimeric antigen receptor (CAR) T-cell therapy is a revolutionary cellular immunotherapy strategy that has transformed the treatment of B cell malignancies ...
Cabozantinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Immunotherapy with monoclonal antibodies, such as ...
This study is being performed to understand the causes of drug resistance and to improve the treatment options for patients diagnosed with B-cell cancers. We ...
mayo-mobile-logo-image. Menu; Search. Search. All Mayo Clinic ... Secondary arthropathies (i.e., sickle cell disease, hemochromatosis, or autoimmune disease).
polycystic kidney disease or Alport syndrome. For those of African descent, sickle cell anemia can be a cause. It's fairly common for no cause of hematuria to ...
... cell. These act as the raw material for future muscles, cartilage, or bone cells, to name a few. But scientists at Mayo report that if the ship isn't ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.